Sign in

EASTMAN CHEMICAL (EMN)

Earnings summaries and quarterly performance for EASTMAN CHEMICAL.

Research analysts who have asked questions during EASTMAN CHEMICAL earnings calls.

Aleksey Yefremov

KeyBanc Capital Markets

6 questions for EMN

Also covers: ALB, ALTM, AXTA +14 more

David Begleiter

Deutsche Bank

6 questions for EMN

Also covers: ALB, APD, ASH +24 more

Vincent Andrews

Morgan Stanley

6 questions for EMN

Also covers: ALB, APD, AVNT +20 more

Frank Mitsch

Fermium Research

5 questions for EMN

Also covers: AVNT, CE, CTVA +13 more

Kevin McCarthy

Vertical Research Partners

5 questions for EMN

Also covers: ALB, ALTM, APD +17 more

Patrick Cunningham

Citigroup

5 questions for EMN

Also covers: ALB, APD, AXTA +17 more

Salvator Tiano

Bank of America

5 questions for EMN

Also covers: ADM, BG, CE +7 more

Jeffrey Zekauskas

JPMorgan Chase & Co.

4 questions for EMN

Also covers: ALB, APD, ASH +30 more

John Ezekiel Roberts

Mizuho Securities

4 questions for EMN

Also covers: ALB, APD, ASH +21 more

Laurence Alexander

Jefferies

4 questions for EMN

Also covers: AIQUY, ALB, APD +27 more

Josh Spector

UBS Group

3 questions for EMN

Also covers: ALB, AMBP, APD +27 more

Michael Sison

Wells Fargo

3 questions for EMN

Also covers: ALB, APD, ASH +15 more

Arun Viswanathan

RBC Capital Markets

2 questions for EMN

Also covers: ALB, AMBP, AMCR +25 more

Duffy Fischer

Goldman Sachs

2 questions for EMN

Also covers: APD, AXTA, CC +9 more

James Cannon

UBS Securities

2 questions for EMN

Also covers: CE, ESI, GLW +3 more

Michael Leithead

Barclays

2 questions for EMN

Also covers: AMBP, APD, AVY +15 more

Mike Sison

Wells Fargo

2 questions for EMN

Also covers: CE, IFF, OLN +1 more

Aziza Fakhri

Fermium Research

1 question for EMN

Eric Zango

Citigroup

1 question for EMN

Joshua Spector

UBS

1 question for EMN

Also covers: ALB, AMBP, APD +37 more

Patrick Fischer

Goldman Sachs

1 question for EMN

Also covers: APD, AXTA, CC +8 more

Recent press releases and 8-K filings for EMN.

Eastman Chemical CFO outlines Q4 2025 outlook and strategic priorities
EMN
Guidance Update
Demand Weakening
New Projects/Investments
  • Q4 earnings: Advanced Materials & Additives expected in line, Chemical Intermediates below breakeven, fibers destocking deeper; EPS anticipated below $0.75 versus prior $0.75–1.00 range.
  • Inventory management: decisive destocking actions in Q3 amid customer destocking and lengthy specialty plastics supply chains; inventories should be at optimal levels by end-2025.
  • Cash and liquidity: on track to approach $1 billion in cash for full-year 2025, with Q3 inventory reductions converting to cash in 2026.
  • CapEx and cash-flow guidance: 2025 CapEx of $550 million, 2026 base CapEx run‐rate of $400–500 million, targeting flat-to-growing free cash flow and a $400 million dividend run-rate.
  • Circular recycling investment: Kingsport methanolysis facility targeting 130 percent throughput via debottlenecks; second-plant expansion paused pending DOE review to optimize capital efficiency.
3 days ago
Eastman Chemical updates 2025 outlook at Citi Basic Materials Conference
EMN
Guidance Update
Demand Weakening
New Projects/Investments
  • Q4 earnings are now expected below $0.75/share (vs. prior $0.75–$1 range) due primarily to weaker Chemical Intermediates demand, a prolonged turnaround and continued fibers destocking.
  • Overall demand is lighter than anticipated but has been largely offset by strong cost control and high utilization; Specialties segments are in line with prior guidance while CI is now forecast to be below break-even.
  • Inventory actions taken in Q3 position the company to generate approaching $1 billion of cash in 2025, with 2026 free cash flow set to be flat to growing on a $400 million CapEx run rate and $100 million of self-help cost savings.
  • The Kingsport methanolysis facility is targeting a 130% debottleneck, with the proposed Longview expansion paused pending DOE discussions; further low-CapEx expansions are being evaluated to meet customer demand and enhance circular-recycling capacity.
3 days ago
Eastman Chemical updates Q4 outlook and 2026 initiatives at Citi 2025 Basic Materials Conference
EMN
Guidance Update
Demand Weakening
New Projects/Investments
  • CFO Willie McLain expects Q4 EPS to come in below the prior guidance of $0.75–$1.00, primarily driven by weaker demand and extended turnaround in the Chemical Intermediates and Fibers segments.
  • Demand in Advanced Materials and Additives & Functional Products is lighter than anticipated but is being offset by strong cost control and plant utilization; Chemical Intermediates is now forecasted slightly below break-even for Q4.
  • Inventory reduction actions in specialty plastics and fibers, combined with ongoing cost‐structure improvements, are on track to generate ~$1 billion of cash in 2025; the company realized $75 million of savings in 2025 and targets an additional $100 million in 2026.
  • The Kingsport methanolysis plant is operating robustly and is being optimized toward 130% capacity, underpinning growth in circular packaging applications and informing plans for future low-capex recycling expansions.
3 days ago
Eastman Chemical outlines Q4 2025 headwinds and 2026 recovery
EMN
Guidance Update
Demand Weakening
  • Expects Q4 2025 to be weaker than Q3 due to normal seasonality and inventory destocking; forecasts a rebound in Q1 2026 driven by asset utilization tailwinds, seasonal demand recovery, methanolysis plant ramp-up, and cost actions.
  • Targets $75 million of net cost savings in 2025 and has raised the 2026 net savings goal to $100 million (over $300 million gross) through productivity improvements, footprint optimization, and AI deployment.
  • Anticipates a meaningful increase in revenue and EBITDA from the circular polyester methanolysis plant, alongside innovation growth in advanced materials (HUD, EV interlayers, Aventa) and tariff-driven benefits in specialty polyesters.
  • Maintains partnership with Pepsi for Renew™ recycled PET, able to supply baseload demand from Kingsport and deliver average recycled content of 50–75 percent per product.
Nov 4, 2025, 1:00 PM
Eastman Chemical reports Q3 2025 results
EMN
Earnings
Guidance Update
Share Buyback
  • Eastman posted 3Q25 revenue of $2.20 B (–11% YoY) and adjusted EBIT of $210 M (–43% YoY).
  • Executed inventory actions with approximately $200 M reduction from Q2 levels and remain on track for >$75 M in 2025 cost savings.
  • Returned $146 M to shareholders through dividends and share repurchases, and expect FY25 operating cash flow approaching $1 B.
  • Advanced Circular Economy platform, anticipating $60–65 M incremental EBITDA from the Kingsport methanolysis facility in FY25.
  • Maintained FY25 guidance of adjusted EPS $5.40–$5.65, capex ~$550 M, and Corporate Other adjusted LBIT of ~$180 M.
Nov 4, 2025, 1:00 PM
Eastman outlines Q3 2025 results and 2026 outlook
EMN
Guidance Update
New Projects/Investments
Demand Weakening
  • Eastman sees full-year volumes down ~4% in advanced materials and ~2% in AFP, and for 2026 anticipates low-single-digit growth in stable markets with stable volumes elsewhere, supported by a $50–75 million utilization tailwind.
  • Targets $100 million of incremental net cost savings in 2026 on top of >$75 million in 2025 (over $300 million gross actions), including a 7% headcount reduction and AI-driven productivity measures.
  • Circular polyester methanolysis (“Renew”) plant at Kingsport is hitting 90% yields, with a feasible 30% capacity expansion and expected revenue/EBITDA lift from ARPET specialty polymers as customer commitments finalize.
  • Faces a ~$30 million tariff-related headwind in fibers (textiles and tow) this year, but views these as cyclical destocking issues set to reverse; chemical intermediates endure oversupply from China but gain tariff protection and may benefit from housing-driven demand recovery.
Nov 4, 2025, 1:00 PM
Eastman Chemical reviews Q3 2025 results and outlines cost and innovation strategy
EMN
Earnings
Guidance Update
Demand Weakening
  • Back‐half distortions from seasonality, tariff‐driven inventory pull-forward and a $100 million asset‐utilization headwind leave full-year volumes down ~4% in Advanced Materials and ~2% in AFP; planning next-year base on stable to modest growth.
  • Targeting $100 million in net cost reductions for 2026 (on top of $75 million in 2025) and a utilization tailwind of $50 million–$75 million, depending on volume recovery.
  • Innovation ramp includes the circular polyester methanolysis plant, which is expected to meaningfully boost EBITDA, alongside growth in Aventa, Naia textiles and semiconductor solvents.
  • At Kingsport, rPET capacity is running at 90% yields, with a 30% expansion feasible via modest capital during planned shutdowns, and strong customer commitments underpinning a second-plant decision in early 2026.
  • Facing a prolonged manufacturing recession, consumer‐durables demand remains 5%–15% below 2019 levels amid housing weakness; CI and fibers markets contend with global excess capacity and tariff-supported North America margins.
Nov 4, 2025, 1:00 PM
Eastman Chemical reports Q3 2025 results
EMN
Earnings
Dividends
Share Buyback
  • Q3 sales revenue was $2,202 million, down 11% year-over-year from $2,464 million.
  • GAAP EBIT declined to $188 million (adjusted EBIT of $210 million), compared to $329 million (adjusted $366 million) in Q3 2024.
  • Operating cash flow remained strong at $402 million, driven by working capital initiatives including a $204 million inventory reduction.
  • Returned $146 million to shareholders in the quarter through dividends and share repurchases.
  • Company anticipates a “greater than normal seasonal decline in volume” in Q4 amid consumer caution and inventory destocking.
Nov 3, 2025, 9:19 PM
Eastman Chemical announces Q3 2025 results
EMN
Earnings
Guidance Update
Dividends
  • Sales revenue decreased 11% year-over-year to $2.20 B while EBIT fell to $188 M and EPS was $0.40 vs. $1.53 year-ago.
  • Operating cash flow was $402 M, aided by approximately $200 M of inventory reduction, and the company returned $146 M to shareholders via dividends and share repurchases.
  • Maintained cost-reduction targets, on track to lower structural costs by > $75 M in 2025 and ~ $100 M in 2026.
  • Forecasting full-year adjusted EPS of $5.40–5.65 and operating cash flow approaching $1 B.
Nov 3, 2025, 9:15 PM
Eastman Chemical updates guidance and growth outlook at Laguna conference
EMN
Guidance Update
Demand Weakening
New Projects/Investments
  • Eastman expects Q3 EPS below $1.25 and sees Q4 slightly lower sequentially, driven by low utilization and seasonal demand declines.
  • Consumer and trade uncertainties have cut order-book visibility to ~2 weeks (vs. ~6 normal), with automotive steady, durables lagging and building/construction flat at low levels.
  • The company is executing $75–100 M of net cost actions, targeting $1 B operating cash flow in 2025 and reducing Days Inventory Outstanding from ~105 to ~90 days.
  • For 2026, management forecasts $50–100 M benefit from inventory normalization, $75–100 M of structural cost savings, stable-to-growing margins in Advanced Materials/Additives & Functional Products and improved Chemical Intermediates spreads.
  • The Kingsport methanolysis plant remains on track for $75 M incremental EBITDA in 2025, with potential >30% debottleneck capacity uplift and plans for a second facility, pending DOE grant reimbursement (~$30–35 M).
Sep 10, 2025, 7:20 PM

Quarterly earnings call transcripts for EASTMAN CHEMICAL.

Let Fintool AI Agent track EASTMAN CHEMICAL's earnings for you

Get instant analysis when filings drop